Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive data from an ongoing trial.
Recursion Pharmaceuticals ( RXRX +1.91%) was in the headlines on Monday, and for the right reason. One of the biotech company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback